FibroScan
Introduced non-invasive liver scanning in Los Angeles in 2013.
Ruane Clinical Research brought non-invasive FibroScan technology to Los Angeles in 2013, allowing painless liver examinations that can help avoid biopsies in many cases. The company conducts clinical trials focused on HIV, hepatitis B, hepatitis C, Nonalcoholic Steatohepatitis, and HIV prevention through PrEP. Its research team includes physicians and allied health professionals, with sub-investigators and clinical research staff working under a principal investigator. Since 2006, the site has conducted 176 clinical trials, studying therapies from international biopharmaceutical companies. Its work has included a large-scale hepatitis C genotype 4 study among the Egyptian population and participation in the PrEP DISCOVER Study, which provided free STD testing and trial medication to more than 400 patients. Ruane Clinical Research is based in Los Angeles.
Disclosure: Profile information has been compiled from publicly available sources and has not yet been verified by the business.
Category illustration. Illustrative image for this category. Not provided by the business.
Introduced non-invasive liver scanning in Los Angeles in 2013.
Conducted 176 trials since 2006.
Participated in the PrEP DISCOVER Study.
No reviews yet — be the first to review Ruane Clinical Research.
Sign in to write a review
No password needed. We only use your email to confirm the review is genuine.
Tell our moderators what is wrong with the review by this reviewer and we will take a look.